Use of Saccharomyces cerevisiae expressing beta-galactosidase to screen for antimycotic agents directed against yeast cell wall biosynthesis and possible application to pathogenic fungi
Open Access
- 1 April 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (4) , 660-662
- https://doi.org/10.1128/aac.34.4.660
Abstract
Saccharomyces cerevisiae expressing beta-galactosidase was used to develop a screen for compounds active against formation of the yeast cell wall. The screen detailed here is based on the release of beta-galactosidase from cells which had received an osmotic shock.This publication has 10 references indexed in Scilit:
- Synthesis and Evaluation of LY121019, a Member of a Series of Semisynthetic Analogues of the Antifungal Lipopeptide Echinocandin BaAnnals of the New York Academy of Sciences, 1988
- Cell wall of pathogenic yeasts and implications for antimycotic therapy.1986
- CANDIDA ALBICANS: BIOLOGY, GENETICS, AND PATHOGENICITYAnnual Review of Microbiology, 1985
- Effect of Aculeacin A, a Wall-Active Antibiotic, on Synthesis of the Yeast Cell WallMicrobiology and Immunology, 1985
- Transformation of intact yeast cells treated with alkali cationsJournal of Bacteriology, 1983
- In vitro studies of aculeacin A, a new antifungal antibiotic.The Journal of Antibiotics, 1982
- Studies on the mechanism of antifungal action of aculeacin A.The Journal of Antibiotics, 1982
- Classification of Polyene Antibiotics According to Chemical Structure and Biological EffectsAntimicrobial Agents and Chemotherapy, 1979